New antimalarials identified by a cell-based phenotypic approach: Structure-activity relationships of 2,3,4,9-tetrahydro-1H-β-carboline derivatives possessing a 2-((coumarin-5-yl)oxy)alkanoyl moiety.
暂无分享,去创建一个
T. Honma | Takeshi Shimizu | Y. Futamura | N. Watanabe | N. Cho | Hitomi Yuki | D. Takaya | H. Koyama | F. Kobayashi | M. Niikura | Hiroyuki Osada | Ko Kikuzato | H. Hayase | K. Kamisaka
[1] David M. Shackleford,et al. Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials. , 2021, Journal of medicinal chemistry.
[2] E. Winzeler,et al. Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome , 2018, Journal of medicinal chemistry.
[3] D. Hashizume,et al. Structures and Synthesis of Hitoyopodins: Bioactive Aromatic Sesquiterpenoids Produced by the Mushroom Coprinopsis cinerea. , 2018, Organic letters.
[4] F. Diederich,et al. Antimalarial Inhibitors Targeting Serine Hydroxymethyltransferase (SHMT) with in Vivo Efficacy and Analysis of their Binding Mode Based on X-ray Cocrystal Structures. , 2017, Journal of medicinal chemistry.
[5] David W. Gray,et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis , 2015, Nature.
[6] H. Osada,et al. Inhibition of malaria parasite growth by quinomycin A and its derivatives through DNA-intercalating activity , 2015, Bioscience, biotechnology, and biochemistry.
[7] Hongshen Ma,et al. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium , 2014, Proceedings of the National Academy of Sciences.
[8] R. Guy,et al. Antimalarials in development in 2014. , 2014, Chemical reviews.
[9] David M. Shackleford,et al. Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. , 2011, Journal of medicinal chemistry.
[10] Christian Scheurer,et al. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria , 2011, Proceedings of the National Academy of Sciences.
[11] N. Day,et al. Artemisinin resistance: current status and scenarios for containment , 2010, Nature Reviews Microbiology.
[12] David A. Fidock,et al. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria , 2009, Nature Reviews Microbiology.
[13] C. Davis,et al. Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century. , 2009, Journal of medicinal chemistry.
[14] Paul Labute,et al. The generalized Born/volume integral implicit solvent model: Estimation of the free energy of hydration using London dispersion instead of atomic surface area , 2008, J. Comput. Chem..
[15] I. Lennon,et al. A novel synthesis of 5-hydroxy-2,2-dimethyl-10-propyl-2H-pyrano[2,3-f]chromen-8-one , 2002 .
[16] J. Scheigetz,et al. AN IMPROVED SYNTHESIS OF ETHYL 4-HYDROXY-3-METHYLBENZOFURAN-2-CARBOXYLATE , 1988 .